Headline News

 

AstraZeneca’s exclusive global licence agreement for novel oral EGFR inhibitor Zegfrovy in lung cancer with Dizal Pharmaceutical

Posted on July 20, 2026

SkinMedica reinforces its dedication to regenerative science through sustained investment in research and development

Posted on July 20, 2026

Allergan Aesthetics secures approval for Boey the first and only rapid-onset, short-duration neurotoxin for the temporary reduction of frown lines in adults

Posted on July 20, 2026

GSK finalises acquisition of Nuvalent

Posted on July 20, 2026

GSK shares update on CALM-1 and CALM-2 Phase III trials for camlipixant in refractory chronic cough

Posted on July 20, 2026

European Medicines Agency accepts submission to update Bexsero label for single-dose meningitis B booster in individuals aged 10 and above

Posted on July 20, 2026

Lilly moves to acquire AtaiBeckley, strengthening its pipeline of therapies for treatment-resistant depression and broader mental health conditions

Posted on July 20, 2026

Roche set to unveil fresh Alzheimer’s disease findings from its combined pharmaceutical and diagnostics portfolio at AAIC

Posted on July 13, 2026

Roche secures CE Mark for blood test designed to detect tuberculosis infection

Posted on July 13, 2026

Novo Nordisk’s denecimig shows positive long-term safety and efficacy results in Phase 3 haemophilia A FRONTIER extension study at ISTH 2026

Posted on July 13, 2026

Denali Therapeutics to deliver opening plenary address at Alzheimer’s Association International Conference 2026, spotlighting breakthroughs in crossing the blood-brain barrier with biologic therapies

Posted on July 13, 2026

Thermo Fisher Scientific becomes first to receive FBI approval for rapid DNA crime scene profiles eligible for national CODIS searches

Posted on July 13, 2026

GSK licensor Hansoh Pharma reports positive Phase III outcomes for Ris-Rez in Chinese patient population

Posted on July 13, 2026

Jemperli delivers lasting clinical complete responses in dMMR/MSI-H locally advanced rectal cancer

Posted on July 13, 2026

CARDIO-TTRansform Phase III trial update for Wainua in adults with transthyretin-mediated amyloid cardiomyopathy

Posted on July 13, 2026